Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Taxotere®, Eloxatin® and Xeloda® (TEX) in Combination With Herceptin® as Treatment for HER2 Positive Non-resectable Cancer

Odense University Hospital · 2011
ClinicalTrials.gov · Datasets · License: Public Domain · 2011
Open Source ↗
na
adenocarcinoma, adenocarcinoma of the gastro-esophageal, her2, dose finding, taxotere (docetaxel), eloxatin (oxaliplatin), xeloda (capecitabine), herceptin (trastuzumab), interventional, na
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 805632
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.